摘要 |
The present invention provides compounds, which, are novel antagonists for D1/D5 receptors as well as methods for preparing such compounds. In another embodiment, the invention provides pharmaceutical compositions comprising such D1/D5 receptor antagonists as well as methods of using them to treat CNS disorders, obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes. |
申请人 |
SCHERING CORPORATION;BURNETT, DUANE, A.;GREENLEE, WILLIAM, J.;MCKITTRICK, BRIAN;SU, JING;ZHU, ZHAONING;SASIKUMAR, THAVALAKULAMGARA, K.;MAZZOLA, ROBERT;QIANG, LI;YE, YUANZAN |
发明人 |
BURNETT, DUANE, A.;GREENLEE, WILLIAM, J.;MCKITTRICK, BRIAN;SU, JING;ZHU, ZHAONING;SASIKUMAR, THAVALAKULAMGARA, K.;MAZZOLA, ROBERT;QIANG, LI;YE, YUANZAN |